High dose intravenous colistin methanesulfonate therapy is associated with high rates of nephrotoxicity; a prospective cohort study from Saudi Arabia

BACKGROUND: Nephrotoxicity is an important adverse effect of colistin methanesulfonate (CMS) therapy. No data exist on rates and risk factors for colistin-related nephrotoxicity in Saudi Arabia (SA). We conducted a prospective cohort study to identify rates and risk factors for CMS nephrotoxicity in...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ann Clin Microbiol Antimicrob
Main Authors: Omrani, Ali S, Alfahad, Wafa A, Shoukri, Mohamed M, Baadani, Abeer M, Aldalbahi, Sultan, Almitwazi, Ali A, Albarrak, Ali M
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2015
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4301664/
https://ncbi.nlm.nih.gov/pubmed/25591721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12941-015-0062-8
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares